SBN sun biomedical limited

howard digby reverts to non-exec director- cyp

  1. 3,928 Posts.
    lightbulb Created with Sketch. 688
    Howard Digby and Peter Webse were appointed to the board of CYP (formerly ECQ) on 18 May 2012. Howard Digby was made an executive director on 10/9/12.

    http://www.asx.com.au/asxpdf/20120518/pdf/426bsswh5p7d8t.pdf
    http://www.asx.com.au/asxpdf/20120910/pdf/428m6hdpsjxvs2.pdf

    The company then commenced the acquisition of Cynata:

    http://www.asx.com.au/asxpdf/20120910/pdf/428m2clcqk8shk.pdf

    Various other announcements were made such as this one:

    http://www.asx.com.au/asxpdf/20121221/pdf/42c3rnh072vsfl.pdf

    ..increasing ECQs ownership in Cynata, until eventually the option to purchase 100% was exercised:

    http://www.asx.com.au/asxpdf/20130924/pdf/42jk6rms8qnt7d.pdf

    It seems HD and PW were instrumental in this transaction.

    Both HD and PW are also directors of SBN, HD being an executive director.

    IMO todays announcement by CYP may result in HD focussing on SBN and perhaps following a similar route as what he did for ECQ/CYP. Although CYPs value has slipped recently from its highs, it still has a diluted market cap of around $25m (but was double this a couple of months ago)

    IMO this shows what HD and PW can do with a company seeking acquisitions.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.